Alzheimer's treatment within reach after successful drug trial

By: Hannah Devlin Science correspondent |

Alzheimer's treatment within reach after successful drug trial

| Neuroscience | The Guardian

Tablet that ‘switches off’ production of toxic amyloid proteins could be first treatment licensed in a decade if it is also shown to slow mental decline

An Alzheimer’s drug has been shown to successfully target the most visible sign of the disease in the brain, raising hopes that an effective treatment could be finally within reach.

A small trial of the drug was primarily aimed at assessing safety, but the findings suggest it effectively “switched off” the production of toxic amyloid proteins that lead to the sticky plaques seen in the brains of Alzheimer’s patients.

Related: A decade of deadlock over Alzheimer’s treatment may be drawing to a close

Continue reading…

icn-neurocience

Latest news and features from theguardian.com, the world’s leading liberal voice